These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 19371878)

  • 1. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
    Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Sun M; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Jan; 75(1):118-24. PubMed ID: 19864000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.
    Roscigno M; Cozzarini C; Bertini R; Scattoni V; Freschi M; Da Pozzo LF; Briganti A; Gallina A; Capitanio U; Colombo R; Giorgio G; Montorsi F; Rigatti P
    Eur Urol; 2008 Apr; 53(4):794-802. PubMed ID: 18207313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
    BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Zigeuner R; Weizer A; Sagalowsky A; Bensalah K; Raman JD; Bolenz C; Kassou W; Koppie TM; Wood CG; Wheat J; Langner C; Ng CK; Capitanio U; Bertini R; Fernández MI; Mikami S; Isida M; Ströbel P; Montorsi F
    Eur Urol; 2009 Sep; 56(3):512-8. PubMed ID: 19559518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract.
    Komatsu H; Tanabe N; Kubodera S; Maezawa H; Ueno A
    J Urol; 1997 May; 157(5):1622-4. PubMed ID: 9112490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
    Xylinas E; Rink M; Margulis V; Faison T; Comploj E; Novara G; Raman JD; Lotan Y; Guillonneau B; Weizer A; Pycha A; Scherr DS; Seitz C; Sun M; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Gönen M; Shariat SF;
    J Urol; 2013 Feb; 189(2):468-73. PubMed ID: 23253960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
    Roscigno M; Shariat SF; Freschi M; Margulis V; Karakiewizc P; Suardi N; Remzi M; Zigeuner R; Bolenz C; Kikuchi E; Weizer A; Bensalah K; Sagalowsky A; Koppie TM; Raman J; Fernández M; Ströbel P; Kabbani W; Langner C; Wheat J; Guo CC; Kassouf W; Haitel A; Wood CG; Montorsi F
    Urology; 2009 Nov; 74(5):1070-4. PubMed ID: 19883824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
    Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma.
    Abouassaly R; Alibhai SM; Shah N; Timilshina N; Fleshner N; Finelli A
    Urology; 2010 Oct; 76(4):895-901. PubMed ID: 20646743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
    Rouprêt M; Hupertan V; Seisen T; Colin P; Xylinas E; Yates DR; Fajkovic H; Lotan Y; Raman JD; Zigeuner R; Remzi M; Bolenz C; Novara G; Kassouf W; Ouzzane A; Rozet F; Cussenot O; Martinez-Salamanca JI; Fritsche HM; Walton TJ; Wood CG; Bensalah K; Karakiewicz PI; Montorsi F; Margulis V; Shariat SF; ;
    J Urol; 2013 May; 189(5):1662-9. PubMed ID: 23103802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
    Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
    BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.